Business · 06/02/2001Updated: 10/17/2026 · 1 min read
Ashford Blood Bank, Inc. Faces Potential Revocation of FDA Licenses
Summary
The FDA is holding a hearing to consider revoking Ashford Blood Bank's licenses due to difficulties in inspecting the facility and discontinuing blood cell production, which hinders a thorough evaluation of the facility's compliance.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →